Sapheneia/Scannerside Announces FDA Clearance for XR-29 Scannerside DoseCheck

September 7, 2017 — Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to market their XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party vendor-neutral computed tomography (CT) product that makes it affordable to update existing CT scanners and allows compliance with current Medical Imaging & Technology Alliance (MITA) radiation dose management standards.

The Sapheneia-Scannerside proprietary XR-29 DoseCheck solution is specifically designed to provide CT operators, prior to a scan, notifications and alerts of potential radiation doses over a predefined threshold. Scannerside DoseCheck is intended to be installed and used with CT scanners not equipped with these functionalities, independent of age, make and model. This newly introduced DoseCheck system encompasses a proprietary hardware and software solution with additional features that no other third-party solution can offer, according to the companies.

For more information: www.sapheneia.com